Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Widmer

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reviews|November 17, 2010
Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?Margaret von Mehren, Nicolas Widmer
Disaster Medicine and Public Health Preparedness|November 20, 2019
Emergency and Disaster Preparedness of European Hospital Pharmacists: A SurveyLaurence Schumacher, Pascal Bonnabry, Nicolas Widmer
Pharmaceutics|June 27, 2024
Population Pharmacokinetics in Oncology and Its Clinical ApplicationsNicolas Widmer, Monia Guidi, Thierry Buclin
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Example-based support vector machine for drug concentration analysisWenqi You, Nicolas Widmer, Giovanni De Micheli
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Long-term prospective population PK study in GIST patients--letterEtienne Chatelut, Peggy Gandia, Verena Gotta, et al.
BMC Health Services Research|October 20, 2023
Managing the COVID-19 health crisis: a survey of Swiss hospital pharmaciesLaurence Schumacher, Yassine Dhif, Pascal Bonnabry, et al.
Therapeutic Drug Monitoring|March 19, 2013
Systematic review of population pharmacokinetic analyses of imatinib and relationships with treatment outcomesVerena Gotta, Thierry Buclin, Chantal Csajka, et al.
The Lancet. Oncology|November 30, 2010
Who is in charge of assessing therapeutic drug monitoring? The case of imatinibThierry Buclin, Nicolas Widmer, Jerome Biollaz, et al.
Blood|July 19, 2003
Functional consequence of MDR1 expression on imatinib intracellular concentrationsNicolas Widmer, Sara Colombo, Thierry Buclin, et al.
Disaster Medicine and Public Health Preparedness|March 8, 2023
Management of the COVID-19 Health Crisis: A Survey of Swiss Health Authorities' ResponsesLaurence Schumacher, Josiane Tinguely Casserini, Pascal Bonnabry, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reviews|November 17, 2010
Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?Margaret von Mehren, Nicolas Widmer
Disaster Medicine and Public Health Preparedness|November 20, 2019
Emergency and Disaster Preparedness of European Hospital Pharmacists: A SurveyLaurence Schumacher, Pascal Bonnabry, Nicolas Widmer
Pharmaceutics|June 27, 2024
Population Pharmacokinetics in Oncology and Its Clinical ApplicationsNicolas Widmer, Monia Guidi, Thierry Buclin
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Example-based support vector machine for drug concentration analysisWenqi You, Nicolas Widmer, Giovanni De Micheli
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Long-term prospective population PK study in GIST patients--letterEtienne Chatelut, Peggy Gandia, Verena Gotta, et al.
BMC Health Services Research|October 20, 2023
Managing the COVID-19 health crisis: a survey of Swiss hospital pharmaciesLaurence Schumacher, Yassine Dhif, Pascal Bonnabry, et al.
Therapeutic Drug Monitoring|March 19, 2013
Systematic review of population pharmacokinetic analyses of imatinib and relationships with treatment outcomesVerena Gotta, Thierry Buclin, Chantal Csajka, et al.
The Lancet. Oncology|November 30, 2010
Who is in charge of assessing therapeutic drug monitoring? The case of imatinibThierry Buclin, Nicolas Widmer, Jerome Biollaz, et al.
Blood|July 19, 2003
Functional consequence of MDR1 expression on imatinib intracellular concentrationsNicolas Widmer, Sara Colombo, Thierry Buclin, et al.
Disaster Medicine and Public Health Preparedness|March 8, 2023
Management of the COVID-19 Health Crisis: A Survey of Swiss Health Authorities' ResponsesLaurence Schumacher, Josiane Tinguely Casserini, Pascal Bonnabry, et al.
Pageof 6